SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,208,000 | +1758.5% | 27,292 | +3033.4% | 0.00% | – |
| Q1 2021 | $65,000 | -35.6% | 871 | -47.5% | 0.00% | – |
| Q3 2020 | $101,000 | -70.1% | 1,658 | -79.7% | 0.00% | -100.0% |
| Q2 2020 | $338,000 | +724.4% | 8,151 | +462.1% | 0.00% | – |
| Q1 2020 | $41,000 | -95.9% | 1,450 | -73.1% | 0.00% | -100.0% |
| Q2 2019 | $988,000 | +15.2% | 5,400 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $858,000 | +66.0% | 5,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $517,000 | -32.2% | 5,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $762,000 | -59.5% | 5,400 | -55.1% | 0.00% | -66.7% |
| Q2 2018 | $1,882,000 | +116.6% | 12,029 | +122.8% | 0.00% | +200.0% |
| Q1 2018 | $869,000 | -41.6% | 5,400 | -40.3% | 0.00% | -66.7% |
| Q4 2017 | $1,488,000 | +50.3% | 9,045 | -43.1% | 0.00% | +50.0% |
| Q3 2017 | $990,000 | -51.2% | 15,900 | -37.6% | 0.00% | -50.0% |
| Q2 2017 | $2,030,000 | +8.2% | 25,500 | -3.4% | 0.00% | 0.0% |
| Q1 2017 | $1,876,000 | -35.9% | 26,400 | -53.9% | 0.00% | -33.3% |
| Q4 2016 | $2,925,000 | -22.1% | 57,300 | -29.8% | 0.01% | -14.3% |
| Q3 2016 | $3,757,000 | +117.7% | 81,600 | +42.4% | 0.01% | +75.0% |
| Q2 2016 | $1,726,000 | -6.0% | 57,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,837,000 | -45.0% | 57,300 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $3,340,000 | +26.5% | 57,300 | -8.2% | 0.01% | +33.3% |
| Q3 2015 | $2,641,000 | -43.2% | 62,425 | -2.0% | 0.01% | -40.0% |
| Q2 2015 | $4,650,000 | – | 63,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |